UM School of Medicines Institute of Human Virology Recruits Top HIV/AIDS Epidemiologist Shenghan Lai Along with Team of Researchers – Newswise

Posted on August 31, 2020 by Danzig

Newswise Baltimore, MD, August 31, 2018 Robert C. Gallo, MD, the Homer & Martha Gudelsky Distinguished Professor in Medicine, Co-founder and Director of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM), and Man E. Charurat, PhD, MHS, Professor of Medicine, Director of the Division of Epidemiology & Prevention and CIHEB Global Director at the IHV, announced today that Shenghan Lai, MD, MPH and Hong Lai, PhD, MPH, in addition to three staff members, and two more to add, have joined the Institute of Human Virology. The faculty began their positions on April 1 with Professor and Associate Professor academic appointments in the UMSOMs Department of Epidemiology & Public Health.

Dr. Shenghan Lai was most recently Professor of Pathology, Radiology Epidemiology and Medicine at the Johns Hopkins School of Medicine (JHM). He began his research in HIV/AIDS and Sexually Transmitted Diseases (STDs) in the late 1980s. His research interests include epidemiology, drug abuse, HIV/AIDS, STIs, prevention and intervention, cardiac imaging, preventive cardiology, medical consequences of HIV infection, and international health.

Dr. Hong Lai was most recently Associate Professor of Radiology at JHM. Since 2002, she has been the lead epidemiologist on five National Institutes of Health (NIH)-funded studies investigating HIV/cocaine-associated comorbidities. These include coronary calcification, left ventricular regional dysfunction, the presence and development of coronary stenosis, coronary plaque progression and cognitive decline.

We are pleased to have Dr. Shenghan Lai and Dr. Hong Lai join the Institute, said Dr. Gallo, who is also Co-Founder and International Chairman of the Scientific Leadership Board of the Global Virus Network (GVN). Together, they will add depth to our Division of Epidemiology and Prevention and provide opportunities for cross-collaborations within the Institute.

The research team led by Dr. Lai has accomplished a lot, especially for Baltimore City, said Dr. Charurat. We are excited to have them continue scientific advancements here.

Dr. Shenghan Lai has been heavily involved in epidemiology and prevention of HIV infection in countries with greater HIV prevalence for more than 10 years. He has focused on high-risk groups such as intravenous drug users, sex workers, and men who engage in sex with other men. Dr. Lai is recognized as a leading epidemiology researcher in the infectious disease epidemiology, and world renowned for his research on the effects of HIV infection and cocaine use on sub-clinical cardiovascular disease. He is the principal investigator of several NIH-supported studies, focusing on HIV natural history and cardiovascular complications of HIV and drug abuse. Dr. Lai received his degrees from Peking Union Medical College in Beijing, China, and the Uniformed Services University of the Health Sciences in Bethesda, Maryland. He has more than 250 peer-reviewed publications and numerous book chapters.

The Institute, led by Dr. Gallo, has a long history of serving the medically underserved African American population in Baltimore, said Dr. Shenghan Lai. We look forward to further exploring why HIV or other factors influence comorbidities among one of the poorest communities in this country. Our highest priority is to use science as a weapon to fight against health disparities and IHV is the best place for us to achieve our goals.

Dr. Hong Lai is the lead author of several publications demonstrating that the use of cocaine promotes subclinical coronary atherosclerosis in users with HIV infection. Further, she identified that reduced cocaine use with a cash-based incentive intervention was significantly associated with a lowered endothelin-1, endothelial marker, and reduced coronary plaque burden in chronic cocaine users with existing coronary plaques.

In addition to growing our cardiovascular research, we look forward to expanding our studies in two new areas., said Dr. Hong Lai. These include improving our understanding of how HIV, drug abuse - especially opioid - and other factors exacerbate cognitive decline among underserved population in Baltimore and reducing health disparities among Baltimores African American population.

With more than 100 publications, Dr. Hong Lais key contribution to science includes the first report that vitamin D deficiency is associated with hidden heart disease among underserved African Americans with HIV infection.

These new faculty members will provide crucial expertise in HIV to help us strengthen our departmental programs in infection control and in health disparities and population health, said Jay Magaziner, PhD, MSHyg, Professor and Chair of the Department Epidemiology & Public Health.

University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, who is University Executive Vice President for Medical Affairs and the John Z. and Akiko K. Bowers Distinguished Professor, added, I want to extend a warm welcome to these new faculty members, and I am eager to see the cross pollination that will take place as they share their expertise and enter into important research collaborations that will advance the field of HIV epidemiology, he said.

About the Institute of Human Virology

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in all of virology. The IHV combines the disciplines of basic research, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably, HIV the virus that causes AIDS. For more information, http://www.ihv.org and follow us on Twitter @IHVmaryland.

About the University of Maryland School of Medicine

The University of Maryland School of Medicine was chartered in 1807 and is the first public medical school in the United States and continues today as an innovative leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland and is an integral part of the 11-campus University System of Maryland. Located on the University of Marylands Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S. with top-tier faculty and programs in cancer, brain science, surgery and transplantation, trauma and emergency medicine, vaccine development and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the nation, but also has a global vision, with research and treatment facilities in more than 30 countries around the world. For more information, visit http://www.medschool.umaryland.edu.

MedMentors On Call aims to provide guidance for premed students – Binghamton University Pipe Dream

Posted on August 31, 2020 by Danzig

As a child of first-generation immigrants, Teri Lam, 17, did not know any physicians or medical students to connect with. Now, by co-founding MedMentors On Call, she aims to connect students in similar positions.

MedMentors On Call is an organization aimed at connecting the medical community by offering services from current medical students such as essay polishing, mock interviews, individualized office hours and more. Lam said stories like hers are not rare, and she is motivated to ensure guidance for medical school applicants.

I have always sought for a community of peers who can encourage and motivate me along my career, Lam wrote in an email. At Binghamton [University], I found that the study resources and mentors who have trekked a similar road were invaluable to my professional and personal growth. In building this company with my co-founder, our mission was to create a platform of guidance and connect premedical students with current medical students with the goal of strengthening the health community.

In addition to such services, MedMentors On Call has launched a seminar series that offers advice about the medical school application process to a larger, national audience. Lam said this has been especially helpful for students because it emphasizes teamwork in the premedical journey which is often perceived as a path one must take alone.

Its hard to find ways to distinguish oneself among other premedical students and sometimes, its even more difficult finding mentors, Lam said. My partner, Sharon [Lam] and I started MedMentors On Call so that students can receive help from current medical students who have recently undergone the medical school process, and, together, we can create a community of professionals helping each other.

Madison Pellnat, a junior majoring in integrative neuroscience, said she has felt this lack of solidarity within BUs premedical community.

I am honored to be able to pursue the premed track at [BU], however, at times it has been an unorganized and difficult field of study, Pellnat said. There is a whole narrative for premed students that professors have to get rid of the weak by making classes so hard that only some get good enough grades for medical school. I find that this outlook really rules out a lot of great and hardworking students and, instead of providing them with the correct tools to utilize to do well in their classes, oftentimes the students are left behind feeling inadequate.

Pellnat believes that MedMentors On Call would be helpful for all premedical students.

Oftentimes we spend so much time studying, that it is difficult to seek out these opportunities on our own, Pellnat said. Furthermore, there are rarely any occasions in which we could candidly talk to doctors about their experiences throughout undergraduate and medical school, which could be immensely inspiring to young premed students. I believe that forming this relationship can strengthen connections for future job opportunities and career advice.

By helping students find their voices, Lam said she hopes that students will gain insight into medical school and see medical school as a clear, attainable goal.

Premedical students volunteer at clinics for countless hours, conduct research even on the weekends and study all night for exams, Lam wrote. All of this boils down to an application, so these few essays must represent who they are as a person, what their motivation for medicine is and what they foresee their future may be like. This is hefty job. With our guidance, we hope that we are able to guide students to dig deeper into the sources of their values and motivation and write something that they are proud of. Confidence will come along with it.

Go here to read the rest:
MedMentors On Call aims to provide guidance for premed students - Binghamton University Pipe Dream

Melanie Etti: The A levels fiasco is part of a wider picture of inequality in medical school recruitment – The BMJ – The BMJ

Posted on August 31, 2020 by Danzig

This years A levels debacle is fresh proof that more needs to be done to widen access to medicine, says Melanie Etti

The initial release of A level grades this year resulted in widespread uproar as almost 40% of students across England saw their predicted results downgraded, causing many to miss out on their places at university. Their final grades had been calculated from their predicted grades using a new algorithmits flaws soon became glaringly apparent. The algorithm favoured students who studied in smaller cohorts and who were from historically high performing schools, meaning the downgrading was inordinately skewed towards students who attended larger, state funded schools.

Among the reports of students who were adversely affected by this downgrading, there was a disappointingly high number of students who had lost out on their places at medical school. Many of the students I saw telling their story were from lower performing schools, less advantaged socioeconomic backgrounds, and of Black or minority ethnic heritagea sad yet unsurprising outcome to say the least.

The government has since backtracked on their decision to use this algorithm in the allocation of A level grades. Nevertheless, the fallout from this initial act has been profound and, in many ways, this years debacle has only forced into clearer view the inequalities that many students from disadvantaged backgrounds face every year in trying to gain a place at medical school.

The lack of diversity in medical school recruitment has long been recognised and documented, with last years annual report by the Medical Schools Council Selection Alliance revealing the extent of the persisting inequalities in the UK. In 2017, just 120 medical school entrants were from households with at least one parent in a lower supervisory and technical occupation, a figure that remained largely static over the preceding decade. While the number of entrants from Black and minority ethnic groups has increased overall, students of Black heritage continue to be under-represented among both standard and graduate entry medical school recruits.

As the child of African migrants, I understand and have experienced firsthand the challenges that many Black students face when applying to medicine, and how feelings of impostor syndrome can develop from being underestimated by those around you. The opportunity to take my A level exams in many ways felt redemptive, and allowed me to prove myself, independently of my circumstances. Sadly, this opportunity was not afforded to A level students this year, meaning their futures hinged almost entirely on estimations of their capability made by others.

Organisations such as IntoUniversity, Generation Medics, and the National Medical Schools Widening Participation Forum have been instrumental in responding to these disparities, providing much needed assistance to students from various social circumstances in their pursuit of a place at medical school. The BMA has also launched a number of initiatives to widen participation in medicine, including the BMA aspiring doctors programme. Many medical schools have also committed to increasing access to medicine by providing foundation years and widening their entry criteria to include the successful completion of an access course. The use of the algorithm in the initial allocation of this years A level grades undermined the efforts of these organisations, essentially building back up the barriers that they strive to overcome and reversing vital work done throughout the year.

While there is often pushback against the notion of introducing quotas to medical school recruitment, I would argue that the outcome of this years A level grade allocation demonstrates exactly why quotas are not only justified, but necessary. One of the main arguments against them is that they would allow disadvantaged students who are not deserving of a place at medical school access to one. Yet the government was complicit in implementing a system that produced the exact opposite outcome.

It therefore seems illogical to view the introduction of quotas as discriminatory when they are merely compensating for an imbalance that already exists. Formalising medical schools recruitment targets for students from underprivileged backgrounds would go some way to mitigating the limitations that their circumstances can impose on their ability to reach their full potential.

The events that unfolded this summer also signify the need for the government to increase their involvement in widening participation schemes. The government cannot hope to improve access to medicine if they are not at least partially invested in the ongoing efforts towards this goal. It is important that we begin to hold them accountable for ensuring that the tools for upwards social mobility are available to those who need them most. The initiatives required to enable these students a real chance at successfully entering medical school must be implemented during their school years, and only the government, through the Department for Education, have sufficient oversight over the state funded education system to be able to realise such a vision.

For many students this year, the glass ceiling was held very firmly in place by a system that purported to be rooted in meritocracy, but instead favoured those in positions of privilege. This may have a lasting effect on their self-esteem, reaffirming any budding feelings of impostor syndrome that might have already started to develop. While the government has announced that they are lifting the national cap on medical school places, many of those who have now fulfilled their grade requirements will still likely see their entry to medical school deferred until next year. This could mean that the effects of this flawed judgment last for years to come.

A vast chasm already separates many disadvantaged school students from a chance of attending medical school. It is imperative that the government begin to put corrective systems in place in order to prevent it from widening any further.

Melanie Etti is a clinical research fellow at the Institute for Infection and Immunity, St Georges, University of London. She is also a mentor with the Black Medical Society, a peer led organisation that provides support for Black medical students, junior doctors, and school students who are considering a career in medicine.

Competing interests: None declared.

Here is the original post:
Melanie Etti: The A levels fiasco is part of a wider picture of inequality in medical school recruitment - The BMJ - The BMJ

Is The Pandemic Fast-Tracking The Disappearance Of The Physical Exam? : Shots – Health News – NPR

Posted on August 31, 2020 by Danzig

Virtual medical appointments are more common since the coronavirus pandemic began. But without physical exams, doctors may miss certain diagnoses and miss out on building relationships with patients. filadendron/Getty Images hide caption

Virtual medical appointments are more common since the coronavirus pandemic began. But without physical exams, doctors may miss certain diagnoses and miss out on building relationships with patients.

Despite a foothold in medicine that predates Hippocrates himself, the traditional physical exam might be on the verge of extinction. The coronavirus crisis has driven more routine medical appointments online, accelerating a trend toward telemedicine that has already been underway.

This worries Dr. Paul Hyman, author of a recently published essay in JAMA Internal Medicine, who reflects on what's lost when physicians see their patients almost exclusively through a screen.

A primary care physician in Maine, Hyman acknowledges he'd already begun second-guessing routine physicals on healthy patients as insurance requirements pushed doctors away from them.

But while Hyman is now providing mostly telemedicine, like many doctors during the pandemic, he writes that he has gained a clearer sense of the value of the age-old practice of examining patients in person. He notes the ability to offer reassurance, be present for his patients and find personal fulfillment as a doctor.

"I think there's something therapeutic about seeing a physician and having them lay their hands on you, and my sense from the feedback I've gotten from the article already is that a lot of people agree that it's therapeutic in its own right and that can be lost without the physical exam," Hyman told NPR.

Hyman spoke with NPR about his experience adjusting to a new world of medicine, one that eases access to health care providers yet has the potential to erode basic human connection.

This interview has been edited for clarity and length.

How has the sudden shift toward mostly virtual visits changed the way you practice medicine?

It's changing almost week to week as I go through and learn, then try to understand what the virtual visit is providing and what it's not providing. It's kind of a learning experiment in real time. In some ways, I am more cautious because I am not sure what I am missing from not seeing the patient in person. And so I try to think through what I would have gained from the physical exam. And if there is enough of a concern about that, then I will advocate for the patient to be examined.

It does give me, for some patients, a lot of insight into the way they live their lives and what their home or work environment is like, which can help me understand more about where their health concerns fit into their overall priorities. I think it's helped me connect with patients in different ways.

What are some things that are much easier to catch through a physical exam or might be missed using telehealth?

We don't really completely understand sometimes what we're missing because we haven't really done medicine this way. I give the example of a patient whose heart is not working as well, and that's causing fluid buildup in their body. For that specific patient, it would have been challenging to make the diagnosis over the video or a phone; it takes touching the patient, being able to listen to their heart, legs, look at their blood pressure and look at the veins in their neck to make that diagnosis.

Another one that I often worry about is dizziness. People can feel dizzy for many reasons. Some of them are very common and not concerning, but occasionally the reason is serious. It's very hard to distinguish some of those reasons on a video trying to walk a patient through an exam.

Beyond the obvious potential for missing a diagnosis, what else is lost in the doctor-patient relationship when you can't do physical exams?

I have to agree with [Abraham Verghese's] description of a ritual, that there's something about coming into the office and going through a history and being examined and that ritual provides real comfort and meaning to both a physician and to the patient.

I mentioned in the article, too, that the exam is an objective piece of data. The patient has a narrative of their illness that the physician is trying to understand to help them feel better, but then the patient may think one thing is going on and the physician may think another. The exam can really be helpful as a piece of science or data that helps clarify what should happen next.

Especially in our world of electronic health records and a lot of other things that can be very distracting, it's that moment in time when the physician is fully present. And I think that can be really supportive, meaningful and important.

You mentioned in the essay that one of the primary roles of a physician is listening to the patient. Are there instances where a virtual visit provides a better environment for doing that?

I think there are, if the patient is fully present during the visit. Sometimes patients can be distracted, doing other things. But there are opportunities in the virtual visit to actually really connect and listen without some of the distractions of a busy office and an exam room. We still have to remember that most of what we're going to learn about a patient's illness is going to be through listening to them.

Insurance providers and volume-based metrics have already reduced the frequency of performing routine physical exams on healthy patients. Has the business of medicine already started to devalue a doctor's touch?

I think what is devalued is humanistic interaction between a patient and a physician development of a relationship and good listening. The way billing codes have worked for primary care, you could put down parts of your physical exam, so it wasn't being completely devalued. But I think it is devaluing to patients to request doctors do visits so quickly. More time is needed, as physicians, to listen to our patients and develop relationships, to think critically about them.

Less time with patients seems to be the enemy for doctors, both virtually and in person.

Yeah, time is the most critical part. And we're just getting less and less of it. I just got an email from a doctor, a pediatric specialist, about how he always does a very complete physical exam because he needs, as we've learned in medical school, to take a step back, think about the big picture and not miss something. That mindset is not valued in the current situation.

You anticipated some wearable technologies that might give more objective information about patients during virtual visits in the future. Are you worried technology may replace the physical exam?

I think there's tremendous benefit to some of the wearable technologies, but I think that society is going to need people to interpret what the wearable technology is telling you. But, we're primary care physicians, we're detectives and we still follow the rules of "when in doubt, examine the patient," right? Right. So a lot of times where I see a patient, when it's not clear what is going on and I'm trying to figure [it] out, I put all these puzzle pieces together.

I think that [the physical exam is] a skill and a tool. I still agree it's a core and fundamental part of being a physician. This isn't, you know, the end to our identity as physicians. I think that we need to evolve. As our data evolves and technology evolves, we need to evolve with it. But we just can't leave it fully behind.

Kristen Kendrick is a board-certified family physician in Washington, D.C., and a health and media fellow at NPR and Georgetown University School of Medicine.

Here is the original post:
Is The Pandemic Fast-Tracking The Disappearance Of The Physical Exam? : Shots - Health News - NPR

University of Medicine and Health Sciences Launches Dextrocardia Podcast – PR Web

Posted on August 31, 2020 by Danzig

Dextrocardia is a medical term for when your heart is the other way around. Caribbean medical schools have many misconceptions, but this podcast might just help you look at things from the other way around.

New York, NY (PRWEB) August 31, 2020

University of Medicine and Health Sciences (UMHS), a small, mission-driven medical school with a commitment to student support and a legacy of successful residency placements in the United States and Canada, today announced the launch of Dextrocardia, a new podcast that explores life as a medical student in the Caribbean. Produced by UMHS and hosted by second-year medical student Nihal Satyadev, the series will feature conversations with fellow medical students, UMHS faculty, and medical practitioners and focus on the unique challenges faced by Caribbean medical students in the era of COVID-19, career advice, and the role of healthcare workers in the context of social justice issues and the Black Lives Matter Movement. The first episode is now available at https://dextrocardia.podbean.com/ and all major podcast platforms, including Apple, Google, Spotify, and YouTube.

As the most popular alternative path to becoming a doctor in the United States and Canada, the journey of a Caribbean medical student is fraught with ups and downs. From sleepless nights studying to the overwhelming relief upon passing the all-important Step 1 exam and the euphoria of matching into a dream residency, Dextrocardia tells this story through conversations with medical students, faculty, and healthcare practitioners. The series seeks to dispel common misconceptions about Caribbean medical schools and impart practical advice to students in Basic Science, clinical rotations, and undergraduate programs.

Dextrocardia is a medical term for when your heart is the other way around, said podcast creator and host Nihal Satyadev. Caribbean medical schools have many misconceptions, but this podcast might just help you look at things from the other way around.

Prior to enrolling at UMHS, Satyadev earned his Masters in Public Health from George Washington University and a BA from the University of Redlands. A social entrepreneur and Alzheimer's advocate, Satyadev is the CEO and co-founder of The Youth Movement Against Alzheimer's, a 501(c) 3 nonprofit organization providing opportunities for college and high school students to advocate, research, and provide care for those battling with the disease. Satyadev has also published research assessing the correlation between Alzheimers Disease and periodontal disease.

Episode 1 of the series features Satyadevs interview with UMHS student Stephanie Vang. In this premiere episode, Vang discusses her work as a teachers assistant (TA) for anatomy and shares advice for fellow students about what it takes to get an A in the class - a standard course taught in the Basic Science portion of medical school.

Discussion topics for upcoming episodes include:Conversation with an Anatomy TA Conversation with a Histology TAConversation with a Neuroscience TAConversation with a Biochemistry TAMedical Research - How medical students can pursue researchBlack Lives Matter - How medical students can get involved, plus a deep dive into racial inequities in healthcare, medicine, and medical education

Dextrocardia is now available on Apple Podcast, Google Podcast, Spotify, and YouTube with new episodes dropping on alternate Tuesdays at 5 am EST. To access the latest episodes and information about the podcast, visit https://dextrocardia.podbean.com/.

About UMHSThe University of Medicine and Health Sciences (UMHS), is a small, mission-driven medical school with a commitment to student support and a legacy of successful residency placements in the United States and Canada. UMHS was founded in 2007 by medical education pioneers Warren and Robert Ross to deliver a highly personalized school experience. Graduates of UMHS earn a Doctor of Medicine degree (MD) and qualify to practice medicine throughout the United States and Canada. Students begin their Basic Science studies in St. Kitts, West Indies, and complete their clinical training in the United States. With an unprecedented 96% student retention rate, the vast majority of students that begin their medical studies at UMHS go on to obtain residencies. For more information visit https://www.umhs-sk.org/.

Share article on social media or email:

Link:
University of Medicine and Health Sciences Launches Dextrocardia Podcast - PR Web

Black Health Matters: New Surgeon at SSM Health Seeks to Raise the Standard of Care for Women of Color – St. Louis American

Posted on August 31, 2020 by Danzig

Diversity and inclusion to me means that everyone out there has the same access to health care and the same quality of health care, not just health care, said Dr. Jovita Oruwari, an oncologic breast surgeon at SSM Health DePaul Hospital.

According to the Centers for Disease Control, black women and white women get breast cancer at about the same rate, but black women die from breast cancer at a higher rate than white women a rate of about 40 percent higher. In her new role as an oncologic breast surgeon at SSM Health DePaul Hospital, Dr. Jovita Oruwari seeks to reverse this statistic. Diversity and inclusion to me means that everyone out there has the same access to health care and the same quality of health care, not just health care, said Oruwari, who began her new role on September 1. Its got to be quality of care. Everyone deserves that because everyones health matters. Its really about access.

To do this, sometimes it means bringing health care to areas where it can be easily accessible to those in need or bringing people to health care facilities.

We need to try to do things to be able to achieve equitable health care, Oruwari said.

Its so important because as for people of color and breast cancer, we know that the rates of breast cancer are higher in white women, but when black women do get breast cancer, we are more likely to die from the disease. This shouldnt be so.

Reasons for this disparity are varied. Sometimes, black women present symptoms later than other racial groups. Other times, black women seek treatment later, Oruwari said.

We need to find a way to bridge that gap (in order) to make health care available so that we can decrease those mortality numbers, she said.

Female physicians of color are rare. African-American doctors who actively practice medicine make up only 5 percent of the total number of physicians in the United States, according to a 2018 self-reported survey by the Association of American Medical Colleges (AAMC). Data documenting the number of African-American women who are breast surgeons was unavailable by press time. However, according to a 2013 Women Physician Workforce data chart from the AAMC, black women made up 7 percent of active physicians in the U.S. workforce. Currently, the American Society of BreastSurgeons (ASBS) has a membership of 2,950 in the U.S. workforce, according to ASBS personnel.

Oruwari, discovered the idea of becoming a breast surgeon during her residency. I was fortunate enough during my residency to rotate and work with a female surgeon who did breast surgery, and that had a profound effect on me, Oruwari said. At the time, Oruwari didnt know that becoming a breast surgeon was a career path available to her.

I went to medical school under the premise of wanting to be a doctor so that I could help people, and I wanted specifically to be a gynecologist because I was a woman, and thats what we did.

And then, somewhere towards the end of medical school, I happened to go through my general surgery rotation and I loved it! I loved being in the operating room. I loved holding a scalpel in my hand. I loved opening up the body and curing illnesses and diseases. It was just really fascinating to me. Just being in the operating room, to me, felt like home.

Also, at the time, breast surgery wasnt a specialty. The female physician who Oruwari shadowed had been performing breast surgery for years, Oruwari said.

She was really a pioneer, Oruwari said. As a woman doing breast surgery, I loved the way she interacted with her patients.

While the discovery of becoming an oncological breast surgeon fascinated Oruwari, she said the micro aggressions she faced during her residency were challenging.

I was told, Maybe you should do a different specialty than this, Oruwari said. A lot of times, as a person of color going through training, your mind is really numb to everything that you go through because the goal is to get through it. So, a lot of those things (micro aggressions), I really didnt think about until recently.

It took her ten years to go back and visit the hospital where she trained because of the stress and not wanting to be reminded of discrimination. During that time, she said, you wonder whether or not youve experienced racism or sexism. Looking back, Oruwari said she had the support of family, medical school staff and colleagues.

Oruwari is a native of Imo State, Nigeria, and moved to the United States with her family when she was 11. She grew up on the East Coast in New Jersey and New York. She then completed medical school at the University of Medicine and Dentistry of New Jersey (UMDNJ)-University Hospital, a residency at UMDNJ-University Hospital and a fellowship in surgical breast oncology at Brown University Women and Infants Hospital in Providence, Rhode Island. The St. Louis Cancer and Breast Institute recruited her in 2001.

Oruwari hopes her presence at SSM Health DePaul Hospital will encourage more black women to seek regular checkups, as well as seek follow-up treatment earlier if they suspect or discover a problem.

Representation matters, she said. Im hoping that my being there as a person of color will give me more visibility to (black women) and that they know I am there for them.

Im going to be a part of their breast wellness and get them that next level of care that they may not have had.

Oruwari said she also hopes that through her representation she will encourage more black youth to consider a career in medicine and offered some advice.

Do a lot of research in medicine, and look at different medical specialties, she said. Volunteer at a hospital to make sure that you like it. Expose yourself to different doctors and shadow physicians in both offices and surgery.

While youth will need to wait until high school to visit hospitals, Oruwari encourages students to start thinking of careers early.

I think that when careers are talked about to kids, its got to start young, in elementary school. Make medicine an option. Kids need to see physicians that look like them. This is only a beginning.

New med school scholarships to support students from Kentucky – MU The Parthenon

Posted on August 31, 2020 by Danzig

New Marshall School of Medicine scholarship to support students from Kentucky

First-Year medical students are now able to receive the Dr. Bobby L. and Eric K. Hardin Miller Scholar- ship, preferring incoming medical students from Boyd or Greenup counties in Kentucky. The scholar- ship will be renewable for three additional years, pending normal academic progress.

Kentucky natives Bobby L. and Eric K. Hardin Miller established this scholarship because they, want students from backgrounds similar to ours to have the opportunity to benefit the way I have as a son or daughter of the school of medicine. stated Miller.

Bobby L. Miller, M.D., graduated from Marshalls School of Medi- cine in 1997. He also completed his

medicine-pediatrics residency at Marshalls medical school, then proceeded to complete a neonatol- ogy fellowship at Baylor University in Houston, Texas. He is currently a neonatologist with Marshall Health and has also served as Vice Dean of Medical Education at Marshalls School of Medicine since 2013.

Eric K. Hardin Miller earned his Bachelor of Science from Shawnee State University in Portsmouth, Ohio, and a Master of Arts in Counseling from Morehead State University in Morehead, Kentucky. He also worked with Marshalls ac- celerated B.S./M.D. program in its early years as well as with standard- ized patients in Marshalls clinical skills lab.

Both have graciously hosted the annual Marshall Medical School fun- draiser, Standing Out In Our Field, for the last six years and will continue to in 2021 due to the pandemic.

Continued here:
New med school scholarships to support students from Kentucky - MU The Parthenon

New MCG chief of radiology uses creative imaging to communicate with patients – The Augusta Chronicle

Posted on August 31, 2020 by Danzig

Amanda King @kingamandap

MondayAug31,2020at7:00AM

Dr. Michael Winkler says you cant predict the future, but he thinks the Medical College of Georgia at Augusta University is on its way to being one of the top medical schools in the country and he plans to be a major part of that.

The new chief of cardiology and thoracic radiology plans to enhance the use of 3D and 4D images that show patients what their issues are instead of using flat images on a screen. The images help to better explain medical complications and upcoming procedures to patients who might only have a high school education, he said.

"If they have, for example, a congenital heart defect, we can show them the part that is healthy and the part that isnt," he said. "That gives them empowerment."

Those images will also help medical students and surgeons as they prepare for procedures.

Winkler hopes to continue to expand the free lung cancer screenings at the hospital. Annual screenings are recommended for asymptomatic adults age 55 to 80 who have a 30-pack per year smoking history and currently smoke or have quit smoking within the past 15 years.

With 150,000 Americans dying of lung and bronchial cancer each year, the screenings could save lives. The U.S. Preventive Services Task Force found that annual screening for lung cancer in high-risk patients can prevent a substantial number of lung cancer-related deaths. In 2017, Georgia had 6,929 cases of lung and bronchial cancer.

"Its a powerful tool and tremendous value," Winkler said.

Winkler comes to AU from the University of Kentucky College of Medicine and UK Health, where he was an associate professor and director of UK Healths Gill Heart Institute International Research and Education Fellowship in Cardiovascular Imaging. His primary reason for choosing to come to AU was Dean David Hesss vision for the medical school and the new facilities and integration at the university.

"Augusta University is on the cusp of becoming a nationally known powerhouse, and because it has medical and dental it will be quickly on par with Georgia Tech and Emory," he said.

See the article here:
New MCG chief of radiology uses creative imaging to communicate with patients - The Augusta Chronicle

Letter from the Editor: The science of sleep – Medical News Today

Posted on August 31, 2020 by Danzig

Given the unprecedented challenges of recent months, its perhaps unsurprising that many of us are experiencing sleep deprivation.

In a recent survey conducted in the United Kingdom, around 75% of respondents said that unease around the COVID-19 outbreak has caused sleep disruption, while 77% reported that lack of sleep has interfered with their day-to-day functioning.

Lack of sleep can lead to several mental and physical health problems, including depression, diabetes, cardiovascular disease, and obesity, highlighting the importance of getting a sufficient amount of shut-eye.

With this in mind, we decided to dig a little deeper into the world of sleep this month. We explored the science behind slumber and provided you with further information and resources to help you get a good nights sleep.

Within our news content, we investigated the connection between sleep and mental health, and examined why the COVID-19 pandemic appears to have altered our nighttime dreams.

Definitely, people are reporting more dream recall, more vivid dreams, more bizarre dreams, and more anxious dreams since March, Deirdre Barrett, Ph.D., an assistant professor of psychology in the Department of Psychiatry at Harvard Medical School in Boston, MA, told us.

We aimed to dispel some of the widespread myths surrounding sleep with the first of our Medical Myths series. Does your brain really shut down during sleep? This article helps clear things up.

We also looked at racial disparities in sleep, including why Black Americans are more likely to experience sleep deprivation than white Americans. In a follow-up piece, physicians weighed in on what might explain these disparities.

To find more information and resources on sleep, visit our dedicated hub.

Continuing our coverage of racial disparities, we recently published an article on how to be an ally. This important piece highlights the need for all of us to be active in the fight against racism.

The burden of fighting against racial inequality must not fall on Black people exclusively. The recognition of this fact is necessary when fighting to keep the movement alive in demanding for tactical change.

In alignment with World Mosquito Day this month, we took an in-depth look at how climate change has impacted the spread of West Nile virus in the United States. Its certainly an interesting read.

Other content that has piqued your interest this August includes our coverage of research suggesting that an existing drug called Ebselen previously used to treat bipolar disorder and hearing loss may help combat COVID-19. You were also interested in our article on a study that suggests COVID-19 symptoms may appear in a certain order.

For those of you who wish to take a break from COVID-19-related news, the latest in our Recovery Room series looks at whats been happening elsewhere in the world of medical research.

Is there a health topic youd like to read more about? Let us know by emailing us at editors@medicalnewstoday.com. You can also reach out to us on Facebook and Twitter.

Ill return next month with more on what youve been reading.

Until then, be safe, happy, and healthy.

Honor Whiteman, Editorial Director

Visit link:
Letter from the Editor: The science of sleep - Medical News Today

Impossible Foods CEO on finding meat’s magical ingredient, pitching VCs and convincing meat-loving chefs to serve a vegan burger – CNBC

Posted on August 31, 2020 by Danzig

In 2011, at the age of 57, Stanford biochemistry professor Pat Brown took a leap faith and quit his job to launch plant-based "meat" company Impossible Foods. He did it because wanted to help solve one of the world's biggest problems before he retired.

"The use of animals as a technology in food production is, by a huge margin, the most destructive technology on earth in the history of our species," Brown tells CNBC Make It.

Today, Impossible Foods, best known for its juicy, meat-tasting vegan burger, is valued at more than $4 billion. Its burgers are served in more than 17,000 restaurants worldwide, including via partnership deals withBurger King, White Castle and Starbucks. It's also sold in8,000 grocery stores,

Here, Brown talks withCNBC Make It about his life before Impossible Foods, his first investor pitch meeting and where he sees the brand going. The interview has been edited together for length and clarity.

CNBC Make It: Today, you are the founder of Impossible Foods. But talk to me about life before Impossible Foods.

Pat Brown: I grew up assuming that I ever did about 50% of my childhood was in the Washington, D.C. suburbs and the other 50% was split in Paris [France] and in Taipei [Taiwan]. And I wasn't a very good student. I was capable, but I had very little interest in school. Fortunately, when it was time for me to go to college [in the 1980s], it was a time when the fraction of people who tried to go to college was a lot lower. So I was able to get into the University of Chicago, which is where I went for undergrad and then I stayed there for my M.D. and Ph.D. [in biochemistry].

I wanted to have more of tangible impact on the world ... so I decided to go into biomedical research. And then I did a pediatrics residency, so I spent three years as a pediatrician in Chicago, at Children's Memorial Hospital. I'd have a 36-hour non-stop day. But I loved it because you felt every moment like you were helping people.

Let's move forward to 2009. You were 57 and a professor at Stanford Medicine, Stanford University's medical school, and you took a sabbatical. How did that lead to the creation of Impossible Foods?

I used the [sabbatical] to try to figure out, what's the most important problem in the world is that I might be able to contribute to solving? The use of animals as a technology in food production is, by a huge margin, the most destructive technology on Earth in the history of our species. And once I realized that, it was a no-brainer.

Relatively quickly it became clear that you are not going to solve the [meat consumption] problem by regulation, education or trying to persuade people. Even most environmentalists that go to climate and environmental conferences are eating steak for dinner. They're not going to stop eating foods that are a big source of pleasure in their daily lives.

So that meant that the only way to solve the problem is to understand what consumers love about these foods and do a better job of delivering it than the current industry does. That means competing in the marketplace and pulling the economic rug out from under that industry. I had to start a company to make those changes and that's why I founded Impossible Foods.

What was your first pitch to get funding for Impossible Foods like?

You can't walk a block in Palo Alto [California, where Stanford is located] without tripping over a venture capitalist. I went to talk to three of the big VC firms but I was naive about what drives venture investors. It's not the same thing that drives me, it turns out.

The message that really snapped them to attention is that the there was, at that time, a $1.5 trillion global market being served by a technology [meat production] that has fundamentally not been improved since prehistoric times. And it's just waiting to be taken down by better technology.

But that was kind of like my last [pitch deck] slide. Now, I am much more upfront about this, saying that is a humongous prize for whoever can develop the technology to replace animals in the food system.

How did you create the Impossible Burger?

The premise was this is a scientific problem. We needed to understand in molecular detail how meat works.

From a nutritional standpoint, the problem was already solved [by plant-based] protein. Just to put it in perspective, the global soybean crop occupies .8% of Earth's land area and produces 150% as much protein as in all the meat consumed globally. And it uses way less fertilizer, pesticides and water than the animal agriculture industry. And it's cheaper by far.

The unsolved problem is deliciousness. So we had to study: What makes meat delicious?

We hired molecular biologists, biochemist, biophysicist and basic scientists because the the problem was not making food. It was understanding how this particular food works to create those emergent properties that people crave. So, they got started working on understanding what makes meat delicious.

And how did you find the magic ingredient, heme?

When you cook meat some kind of magical happens there's an explosion of aroma and it's flavor profile becomes completely different. When you have an explosion of chemical activity like that, to me that suggests that there was a catalyst in there.

What I knew was that heme besides being the molecule that carries oxygen in your blood making it red is one of the best catalysts in nature. And it's staring right at you, because it's responsible for the red or pink color of meat. So, it's just screamingly obvious.

You can basically take vegetable broth but if you throw in heme, it tastes like meat.

When you first introduced Impossible Burger, why did you market it to restaurants as opposed to consumers?

We debuted it with a handful of world renowned, uncompromising chefs, the first of which was Dave Chang, who once made a big splash by banning on principle every vegetarian item from his menu. So this guy is a meat guy to the bone, and the perfect person for us to launch with. Someone like Dave Chang, Traci Des Jardins, Brad Farmer and Chris Cosentino, these very meat-focused chefs, wanted it on their menus. So you would be insane not to take advantage of that.

Where do you see Impossible Foods going?

I think last year we increased our sales by about threefold. This year, it's very likely to be more than twofold. In order to achieve our mission[to eliminate the need to make food from animals], we have to grow on average about twofold every year for the next 15 years.

More than 90% of the people who ever want impossible burger are current meat eaters. We need to convince them to try [Impossible Burger]. Once we do that, I think we're in.

Check out:Americans spend over $5,000 a year on groceriessave hundreds at supermarkets with these cards

Don'tmiss:

Beyond Meat CEO on early naysayers: A new idea is crazy until its not

Whole Foods CEO on plant-based meat boom: Good for the environment but not for your health

Impossible CEO on critics who say plant-based meat is unhealthy: 'It's bull----'

Excerpt from:
Impossible Foods CEO on finding meat's magical ingredient, pitching VCs and convincing meat-loving chefs to serve a vegan burger - CNBC

Chitosan Market : Global Industry Analysis By Size, Growth Rate, Share, Covid-19 Impact And Trends With Forecast To 2020 2026 | Leading Players-…

Posted on August 31, 2020 by Danzig

Data Bridge Market Research has recently published the Global research Report Titled: Chitosan Market

Chitosan Market report is an excellent report that makes it possible to the Chitosan industry can be highly benefited with this market research report which brings market and competitive landscape clearly into the focus and help make better decisions. Market segmentation has also been performed in detail based on various parameters that include applications, verticals, deployment model, end user, and geography. Expert solutions combined with potential capabilities prepare this winning Chitosan Market document to be outperforming for the Chitosan

Data models employed for the research methodology are vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. Not to mention, the data is collected only from the dependable sources such as journals, newspapers, company websites and annual reports of the companies on which Chitosan industry can rely confidently. Businesses are highly relying on the different segments covered in the market research report which gives better insights to drive the business into right direction. The market studies, insights and analysis carried out in this credible Chitosan Market research report keeps marketplace clearly into the focus which helps achieve business goal.

The latest report includes Impact of Coronavirus(Covid-19) on the Chitosan Industry, it includes on Industry Upstream, Industry Downstream, Industry Channels, Industry Competition, and finally on Industry Employment.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-chitosan-market

(***Our Free Sample Copy of the report gives a brief introduction to the research report outlook, TOC, list of tables and figures, an outlook to key players of the market and comprising key regions.***)

Global chitosan market is expected to register a healthy CAGR of 14.8% in the forecast period of 2019-2026. The rise in the market value can be attributed to the growing awareness about health globally, unique properties of chitosan and availability of abundant raw material. The report contains data of the base year 2018 and historic year 2017.

The Leading Market Players Covered in this Report are :

Panvo Organics Pvt Ltd, Qingdao Yunzhou Biochemistry co., ltd., , Advanced Biopolymers AS, meron, Heppe Medical Chitosan GmbH, Kitozyme, LLC, Kraeber & Co. GmbH, Foodchem International Corporation, FMC Corporation, Golden-Shell Pharmaceutical, Primex EHF, Nano3Bio, KOYO CHEMICAL CO.,LTD., Dainichiseika Color & Chemicals Mfg. Co., Ltd., Biothera Pharmaceuticals among others.

Market Definition: Global Chitosan Market

Chitosan is a kind of carbohydrate that is bonded with number of sugar molecules. It contains chitin and chitosan, which are two naturally abundant and renewable polymers that shows varied properties like non-toxicity, adsorption, nature-friendly and biodegradability. The compound is used for various applications particularly in the industries like agrochemicals, water treatment and cosmetics.

Market Drivers:

Market Restraints:

Regional Analysis Includes:

The Report published on Data Bridge Market Research about Chitosan Market is spread across several pages and provides newest industry data, market future trends, allowing you to identify the products and end users driving revenue growth and profitability. The industry report lists and studies the leading competitors, also provides the insights with strategic industry analysis of the key factors influencing the market dynamics.

Chitosan Market Research Report is a professional and in-depth study on the current state which focuses on the major drivers and restraints for the key players. Industry research report provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market.

Find More Competitor in TOC with Profile Overview Share Growth Analysis @ https://www.databridgemarketresearch.com/toc/?dbmr=global-chitosan-market

Segmentation: Global Chitosan Market

By Source

Grade

ByApplication

Key Insights Of The Report:

Key Questions Answered:

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-chitosan-market

Some of the major objectives of this report:

1) To provide a detailed analysis of the market structure along with the forecast of the various segments and sub-segments of the global Chitosan Market.

2. To provide insights about factors affecting market growth. To analyze the Chitosan Market based on various factors- price analysis, supply chain analysis, porter five force analyses, etc.

3. To provide historically and forecast revenue of the Chitosan Market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and the Rest of the World.

4. Country-level analysis of the market with respect to the current market size and future prospective.

5. To provide country-level analysis of the market for segment by application, product type and sub-segments.

6. To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.

7. Track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Chitosan Market.

Customization Available : Global Chitosan Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

About Us:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process.

Contact:

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

[emailprotected]

View post:
Chitosan Market : Global Industry Analysis By Size, Growth Rate, Share, Covid-19 Impact And Trends With Forecast To 2020 2026 | Leading Players-...

Two UGA professors named to National Academy of Inventors – WGAU

Posted on August 31, 2020 by Danzig

The National Academy of Inventors has named two University of Georgia faculty members to the 2020 class of NAI Senior Members.

Richard Meagher, Distinguished Research Professor of Genetics, and Ronald Orlando, professor of biochemistry and molecular biology, and chemistry, are the first UGA researchers to receive the senior membership distinction. They join a new class of 38 prolific inventors representing 24 research universities along with government and nonprofit research institutes worldwide.

Meagher has dedicated nearly five decades to performing pioneering research across several diverse biotechnology disciplines, including plant molecular genetics, monoclonal antibody development and epigenetics. His research contributions at UGA have led to 58 invention disclosures, eight issued U.S. patents and one pending U.S. application. Hes also co-founded four biotechnology companies based on these technologies. One company, Abeome, is developing therapeutic antibodies against inflammatory and other diseases. Meagher received the UGA Inventors Award in 2004 and the UGA Entrepreneurs Award in 2017.

Consistent encouragement by my colleagues and the creative environment at UGA have been essential to this recognition by NAI and much of my success as an inventor and entrepreneur, said Meagher.

Orlando joined the Complex Carbohydrate Research Center in 1993 and leads a prominent research group dedicated to glycobiology and biochemistry. He holds two U.S. patents and four pending patent applications and has appeared as an inventor on 17 invention disclosures ranging from software to novel compounds and methods of analysis. Orlando has launched three startup companies based on UGA-licensed technology that have raised more than $7.8 million in funding and launched 57 new products. He serves as CEO of GlycoScientific, an Innovation Gateway resident company developing research tools and potential therapeutic antibodies for cancer, and was the inaugural recipient of the UGA Entrepreneurs Award in 2010.

I am deeply honored to have been elected as a senior member of the National Academy of Inventors, but I am not the only person deserving recognition for this honor, Orlando said. Innovation Gateway provided the guidance and infrastructure I needed to move my research into the marketplace.

Innovation Gateway is a key component of the universitys Innovation District initiative to cultivate a comprehensive innovation ecosystem that supports research commercialization, entrepreneurship, industry engagement and experiential learning.

The NAI Senior Member program recognizes national and international academic inventors who have demonstrated success in developing new technologies that benefit society. Senior members are elected biennially and undergo a rigorous selection process by the NAI Advisory Committee, which is composed of elected NAI members and other professionals considered pioneers in their respective fields.

Follow this link:
Two UGA professors named to National Academy of Inventors - WGAU

Global Clinical Biochemistry Analyzer Market 2020: Competitive Landscape Analysis and Future Outlook by Companies, Key Regions, Types and Application…

Posted on August 31, 2020 by Danzig

Clinical Biochemistry Analyzer Market Research

The Clinical Biochemistry Analyzer Market 2020 report includes the market strategy, market orientation, expert opinion and knowledgeable information. The Clinical Biochemistry Analyzer Industry Report is an in-depth study analyzing the current state of the Clinical Biochemistry Analyzer Market. It provides a brief overview of the market focusing on definitions, classifications, product specifications, manufacturing processes, cost structures, market segmentation, end-use applications and industry chain analysis. The study on Clinical Biochemistry Analyzer Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape.

It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global Clinical Biochemistry Analyzer market. All findings and data on the global Clinical Biochemistry Analyzer market provided in the report are calculated, gathered, and verified using advanced and reliable primary and secondary research sources. The regional analysis offered in the report will help you to identify key opportunities of the global Clinical Biochemistry Analyzer market available in different regions and countries.

The final report will add the analysis of the Impact of Covid-19 in this report Clinical Biochemistry Analyzer industry.

To know How COVID-19 Pandemic Will Impact This Market/Industry-Request a sample copy of the report https://www.reportsandmarkets.com/sample-request/global-clinical-biochemistry-analyzer-market-research-report-2020?utm_source=startupng&utm_medium=41

The report scrutinizes different business approaches and frameworks that pave the way for success in businesses. The report used Porters five techniques for analyzing the Clinical Biochemistry Analyzer Market; it also offers the examination of the global market. To make the report more potent and easy to understand, it consists of info graphics and diagrams. Furthermore, it has different policies and development plans which are presented in summary. It analyzes the technical barriers, other issues, and cost-effectiveness affecting the market.

GlobalClinical Biochemistry AnalyzerMarket Research Report 2020 carries in-depth case studies on the various countries which are involved in the Clinical Biochemistry Analyzer market. The report is segmented according to usage wherever applicable and the report offers all this information for all major countries and associations. It offers an analysis of the technical barriers, other issues, and cost-effectiveness affecting the market. Important contents analyzed and discussed in the report include market size, operation situation, and current & future development trends of the market, market segments, business development, and consumption tendencies. Moreover, the report includes the list of major companies/competitors and their competition data that helps the user to determine their current position in the market and take corrective measures to maintain or increase their share holds.

Key questions answered in this report

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a six-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

TABLE OF CONTENT:

Chapter 1:Clinical Biochemistry Analyzer Market Overview

Chapter 2: Global Economic Impact on Industry

Chapter 3:Clinical Biochemistry Analyzer Market Competition by Manufacturers

Chapter 4: Global Production, Revenue (Value) by Region

Chapter 5: Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6: Global Production, Revenue (Value), Price Trend by Type

Chapter 7: Global Market Analysis by Application

Chapter 8: Manufacturing Cost Analysis

Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Clinical Biochemistry Analyzer Market Effect Factors Analysis

Chapter 12: GlobalClinical Biochemistry Analyzer Market Forecast to 2027

Get Complete Brochure @ https://www.reportsandmarkets.com/sample-request/global-clinical-biochemistry-analyzer-market-research-report-2020?utm_source=startupng&utm_medium=41

About Us:

Reports And Marketsis part of theAlgoro Research Consultants Pvt. Ltd.and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Are you mastering your market? Do you know what the market potential is for your product, who the market players are and what the growth forecast is? We offer standard global, regional or country specific market research studies for almost every market you can imagine.

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Edgar Cahoon: ‘There is still so much basic knowledge to learn’ – Chemistry World

Posted on August 31, 2020 by Danzig

Edgar Cahoon is a biochemistry professor and director of the Center for Plant Science Innovation at the University of Nebraska in Lincoln (UNL). His research group conducts basic and applied research on plant lipid metabolism that aims to enhance the nutritional and industrial value of crop plants.

I grew up in Eastern Virginia in the US on a dairy farm. My father had passed away, and my mother got remarried when I was about five years old to a dairy farmer. Later, we went to growing crops soybean and corn and I really developed an interest in plants. I was fascinated by all the chemical diversity that you can see in them.

I wanted to be a scientist. I was just curious about how things work, and I guess science is what you naturally gravitate to when you are that way.

At university, I started out in horticulture, but realised that didnt tell me anything about what I wanted to know, which was how plants work. So, I switched to biochemistry and have been doing plant biochemistry ever since.

My first car was a 1980 Chevrolet Citation, and I got it when I was a sophomore in college at Virginia Tech. I did a cooperative education programme and worked at the Food and Drug Administration in Washington, DC. I needed the car to commute I was part of a carpool and had to drive people around. So yeah, I drove five big men in a little Chevrolet Citation.

I have moved around a lot in my career. I started out working at a large company, after my postdoc. When Ive changed jobs its not because I wasnt performing well, I just wanted more of a challenge and more freedom in my science. It took a lot of courage to make these moves that ended up with me being at a university, but I am happy I did that. Maybe the hardest thing Ive done is to take risks when trying to find a situation that I was most happy with for my career.

In industry, you have to learn how to not be an egomaniac. Youve got to be able to work in teams, and this is quite useful for going to a university. My colleagues who havent been in industry sometimes have a different perception about how they share resources and so forth. Industry is collaborative typically you dont do a project on your own.

I garden a lot, I enjoy that. In the summertime, the tomatoes and cucumbers that we eat are almost all from our garden. But then, during the wintertime and other parts of the year when the garden isnt growing anything , we buy our produce from the grocery store.

I also do a lot of road biking going long distances on the bike. Nebraska is quite nice for that, we have a lot of backroads where the traffic is not so heavy. You can see the countryside on a bicycle, and get some exercise and fresh air. I am part of a cycling club, and they have a 60-mile ride that is not competitive.

We still have so much basic information to learn about how a cell works

Being at UNL, you have to like Cornhusker football [the universitys American football team]. We all keep up with that. There is a lot of local interest in seeing what the team is going to be like for the fall. There is worry that there wont be football this fall.

A coffee shop is my favourite place to think and get work done. I like being away from people and distractions like television, and just focusing on what I do. Sometimes at coffee shops you can also overhear other peoples conversations, and it can be quite good entertainment.

I like to think that I am doing synthetic biology, but I realise that we dont really know what were doing in many cases. We still have so much basic information to learn about how a cell works before we can ever be able to really predictively manipulate it. We talk about synthetic biology that someday we will be able to sit at a computer and have all of this omics data in hand and just dial-in whatever change we want to make but there is still so much basic knowledge to learn.

There maybe is a feeling among the broader scientific community that we have learned everything there is to know on a basic level that we can now just go in and very carefully manipulate things. But we will need to have a major focus on foundational basic research rather than making this huge leap towards translation. We cant lose sight of the importance of foundational research.

Visit link:
Edgar Cahoon: 'There is still so much basic knowledge to learn' - Chemistry World

Comprehensive Report on Biochemical Sensors Market by global COVID-19 impact analysis, industry trends, business strategies, opportunities and…

Posted on August 31, 2020 by Danzig

The new market research report added by Report Ocean focuses on Biochemical Sensors Market. It analyzes the volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Global Biochemical Sensors Market size by analyzing historical data and future prospect. The report contains vital insights on the market which will support the clients to make the right business decisions. This research will help both existing and new aspirants for Biochemical Sensors Market to figure out and study the market needs, market size, and competition. The report incorporates data regarding the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities, and the threats faced by key players during the forecast period.

Impact of COVID-19 on Biochemical Sensors Market

This is a latest report, covering the current COVID-19 impact on the Biochemical Sensors Market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions.

The report also includes the impact of ongoing global crisis i.e. COVID-19 on the Biochemical Sensors Market and what the future holds for it. It provides an analysis of the effects of the pandemic on the global economy. The outbreak has directly disturbed the demand and supply chain. The report also analyzes the financial impact on firms and financial markets. Report Ocean has gathered insights from several delegates of the industry and got involved in the primary and secondary research to provide the clients with data and strategies to combat the market challenges during and after COVID-19 pandemic.

Request Free Sample Report athttps://www.reportocean.com/industry-verticals/sample-request?report_id=HNY38510

Competitive Landscape:

Major market players operating in the Biochemical Sensors Market are identified through secondary research method and market revenue through both primary and secondary research method. We have analyzed the capacity, production, price, revenue, cost, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments of each company mentioned in this report.

Abbott Point of CareAcon LaboratoriesLifeScanSmiths MedicalNova BiomedicalLifeSensorsUniversal BiosensorsBoston ScientificMedtronicBio-RadBiosensor LaboratoriesBiosensors InternationalBayerSysmexABTECH ScientificBioDetection InstrumentsKinesisRocheNeuroSkySensLabYSI Life Sciences

Market Segmentation:

The market segmentation has been done considering various factors such as global supply and demand of Biochemical Sensors Market, common interests and global market share. Additionally, the research report compares the growth rate and production value of the Biochemical Sensors Market across various regions.

By TypeElectrochemical Biochemical SensorsThermal Biochemical sensorsPiezoelectric Biochemical sensorsOptical Biochemical sensors

By ApplicationAgriculturalNutritionalEnvironmentalMedical

By Regions/Countries:

North America

United States

Canada

Mexico

East Asia

China

Japan

South Korea

Europe

Germany

United Kingdom

France

Italy

Russia

Spain

Netherlands

Switzerland

Poland

South Asia

India

Pakistan

Bangladesh

SouthEast Asia

Indonesia

Thailand

Singapore

Malaysia

Philippines

Vietnam

Myanmar

Middle East

Turkey

Saudi Arabia

Iran

United Arab Emirates

Israel

Iraq

Qatar

Kuwait

Oman

Africa

Nigeria

South Africa

Egypt

Algeria

Morocoo

Oceania

Australia

New Zealand

South America

Brazil

Argentina

Colombia

Chile

Venezuela

Peru

Puerto Rico

Ecuador

Rest of the World

Kazakhstan

Some of the Major Highlights of TOC covers:

Chapter 1 Industry Overview

Market Analysis by Regions

Global Biochemical Sensors Market Size Analysis from 2021 to 2026 by Consumption Volume

Global Biochemical Sensors Market Size Analysis from 2021 to 2026 by Value

Global Biochemical Sensors Market Price Trends Analysis from 2021 to 2026

COVID-19 Outbreak: Biochemical Sensors Market

Chapter 2 Covid-19 Impact: Biochemical Sensors Market Competition by Types, Applications, and Top Regions and Countries

Chapter 3 Covid-19 Impact: Production Market Analysis

2015-2020 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

2015-2020 Major Manufacturers Performance and Market Share

Chapter 4 Covid-19 Impact: Biochemical Sensors Market Sales, Consumption, Export, Import by Regions (2015-2020)

Biochemical Sensors Market Sales, Consumption, Export, Import (2015-2020)

Chapter 5 to Chapter 13: Regional Market Analysis

Chapter 14 Company Profiles and Key Figures in Biochemical Sensors Market Business

Company Profile

Product Specification

Production Capacity, Revenue, Price and Gross Margin (2015-2020)

Sales by Types

Chapter 15 Biochemical Sensors Market Forecast (2021-2026)

Biochemical Sensors Market Consumption Volume, Revenue and Price Forecast (2021-2026)

Biochemical Sensors Market Consumption Volume and Growth Rate Forecast (2021-2026)

Biochemical Sensors Market Value and Growth Rate Forecast (2021-2026)

Biochemical Sensors Market Consumption Volume, Value and Growth Rate Forecast by Region (2021-2026)

Biochemical Sensors Market Consumption Volume, Revenue and Price Forecast by Type (2021-2026)

Biochemical Sensors Market Consumption Volume Forecast by Application (2021-2026)

Biochemical Sensors Market Forecast Under COVID-19

The rest is here:
Comprehensive Report on Biochemical Sensors Market by global COVID-19 impact analysis, industry trends, business strategies, opportunities and...

o Aminoanisole Market 2020 Industry Growth by Jiaxing Zhonghua Chemical, WeifangUnion Biochemistry, Seya Industries Ltd, Anhui Haihua Chemical…

Posted on August 31, 2020 by Danzig

Courant Market Research Reports added Latest Research Report titled Global o Aminoanisole Market Status and Trend Report 2015-2025 to its research database. This report gives detailed survey of the market by examining changing aggressive elements of the o Aminoanisole Market. It helps in understanding the key product sectors and their future. It gives pin point analysis of changing rivalry flow and keeps you in front of contenders.

Request Free Sample Report of o Aminoanisole Market Report @ https://courant.biz/report/o-aminoanisole-global-market/39523/

Our Free Complimentary Sample Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology

It offers a forward looking point of view on various elements driving or limiting business sector development. It gives a forecast based on how the market is anticipated to develop. Their key financials, general organization review, weighted SWOT examination, key advancements, developments, land spread, and procedures are contemplated and have been skillfully made in this far reaching o Aminoanisole Market report.

The o Aminoanisole Market report covers a top to bottom focused scene in which key players are profiled. Different producers engaged with the o Aminoanisole Market are surveyed. Research report for o Aminoanisole Market incorporates a worldwide viewpoint. This report investigates o Aminoanisole Market based on its market fragments, chief geologies, and current market patterns. This can bolster the user in settling on educated choices and major key systems.

Download Free PDF Report Brochure @ https://courant.biz/report/o-aminoanisole-global-market/39523/

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

This can bolster the user in settling on educated choices and major key systems. The beat of the market is unveiled in this sector which can enable the user in applying key strategies to attain competitive benefit. Such a top to bottom, far reaching research survey conveys the genuinely necessary esteem expansion, with unbiased measurable analysis and key suggestions, which can be utilized to design future extensions and enhance current position in the o Aminoanisole Market in a specific area.

Imperative areas all over the globe are secured and the patterns, advancements, drivers, restrictions, and difficulties affecting the development of the o Aminoanisole Market over these vital regions are considered. An evaluation of the effect of government strategies and holistic on the market processes is likewise included to give an all encompassing outline of the o Aminoanisole Market future viewpoint.

Inquire more about this report @ https://courant.biz/report/o-aminoanisole-global-market/39523/

Browse Full Report @ https://courant.biz/report/o-aminoanisole-global-market/39523/

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs.

Excerpt from:
o Aminoanisole Market 2020 Industry Growth by Jiaxing Zhonghua Chemical, WeifangUnion Biochemistry, Seya Industries Ltd, Anhui Haihua Chemical...

‘I’m definitely disappointed:’ incoming freshmen face new set of challenges for the fall | The Retriever – The Retriever

Posted on August 31, 2020 by Danzig

Francesca Burton is doing an individualized study in neuroscience and picking up a second major in biochemistry. Photo courtesy of Francesca Burton.

The freshman experience at the University of Maryland, Baltimore County usually includes the bonfire, Involvement Fest, kickbacks in dorms and D-Hall trips. But for this years class of incoming freshmen, many of whom lost part of high school, everything is different now socially-distanced, hybrid or online.

Roshnee Roberts, a biological sciences major and psychology minor, knew March 13 was going to be her last day of high school. Her track season cut short, her plans to speak at graduation cancelled, senior activities and hanging out with friends suddenly not allowed, and her life radically altered.

This fall, shell be attending UMBC from her home, opting not to live on campus. Unfortunately, I was really hoping [that I would be living] on campus. But you know, the way money is set up [its] not happening, which is totally fine, she said.

She was excited to get a placement in a lab, but shes still not sure if shell be able to even go on campus, Roberts said. Everyone else gets to experience all the fun senior activities and I didnt. Now, Im also missing out on freshman year, which is probably the best year, because youre meeting everyone [for the first time], she said.

It leaves her wondering what the future will look like when shes finally able to be on campus under more typical circumstances. Am I going to feel like a freshman? Because everyone else is going to know the [campus], said Roberts.

Luckily, Roberts was able to earn a full scholarship through the Dawg Days: Jumpstart Scholarship to take online classes this summer. Im taking a summer class right now, completely free of cost, which is very exciting, she said. Im taking Math 105, just to get my math credit out of the way.

Computer engineering major Kwadwo Ansah Baah, who lives in Baltimore, is also taking a math credit to get ahead with the help of the Jumpstart Scholarship, and while its not exactly what he had envisioned for his summer, he really likes his professor and class. We all crack jokes to lighten the mood. Im getting to know other people. The Jumpstart Scholarship community is great. We have game nights and everything too, he said.

His outlook is mostly positive, even faced with the adversity of missing out on some activities, hes choosing to look at the situation realistically. I was looking forward [to campus life], but [its] all right. I really understand the way the world is at this moment, he said.

While taking classes from home, his parents have been supportive throughout, giving him the space he needs to complete his schoolwork uninterrupted. My mom and dad understand that this is very important for me. When Im having classes, theyll text me rather than barge into my room, Ansah Baah said, laughing.

His sense of humor hasnt been diminished by the situation at hand, either. He doesnt plan to let the virtual classes stop him from meeting other people or from making others laugh. I believe I can still have the UMBC experience. I still crack jokes [in Zoom or Google Meet] as if you were in an in-person class. I know this pandemic is not going to go on forever, he said.

For others, the pandemic has made them reevaluate what the future looks like. Sarah Nove, an English major, originally thought she wanted to be a journalist while she was working at her high school paper, but when the pandemic hit and the news became more stressful, she had to start turning it off for her mental health. I will say that COVID definitely impacted my ideas, and what I want to be when I grow up and what Im interested in, she explained. And while she still loves editing, shes not sure that being a full-time journalist is the job for her.

When school went virtual in March, her high school newspaper training was turned upside down. I was in charge of training pretty much everybody with the help of some of the section editors. I felt bad on one hand for not being able to pass along the skills that people passed along to me. It was hard for me to feel like I was letting them down but also knowing I couldnt do anything about it, Nove said.

Though beach week wasnt on the docket for Nove, she had plans with her mom to visit Paris and Austria, something that they had been wanting to do for a long time. And thankfully, were pretty confident that well be able to make it work at some point but going on this trip before you become a college student, and have all the responsibilities of college on your plate, it did suck to miss out on that, she said.

Shes spent the summer taking classes and working as a babysitter, a job she loves. However, when it came to making the decision about living on campus, it was devastating to not feel comfortable enough to live in the dorm. I live in a condo with a single mom and a dog. I love it here and its the perfect amount of space for the two of us and our pup. But I was really looking forward to moving out and my mom was really looking forward to having alone time for once in her life, Nove said. Of course, its been hard on her just as much as its been hard on me, so theres the factor just wanting to be out on my own so badly and not being able to. And then on top of that, Im not a person with a huge circle of friends. I was really looking forward to branching out and meeting other people that shared similar interests and values.

While some are opting to stay at home, others, like Francesca Burton, a neuroscience and biochemistry double major, are living on campus this fall. After her plans to visit Canada with her mom and her plans to go to Florida with friends vanished, Burton spent her summer working at the local Boston Market. She hopes that spending the last few weeks of her high school career online has prepared her for online learning in college.

Im definitely disappointed were not going to have in-person classes because I have found I learn better in an in-person setting. But I think by now, Ive just gotten so used to the fact that we will probably have this weird online semester. Ive kind of processed everything, she said.

When it comes to fall activities, COVID-19 has left her mostly unsure. I saw that there was a cooking club that I was interested in. I was thinking of picking up Ultimate Frisbee just as a thing to try, which I think is going to be impacted, she said. So Im a little sad that I wont get wont get to try that out.

But overall, she still sees the fall in an optimistic light. Maryland has been doing a pretty good job on keeping cases down. We havent had a spike yet. I would say Im optimistic that things will go back to normal, said Burton. I think thats all we can do is be optimistic, and just try to make the most of this. I just hope that despite everything being online, we can still just be normal college kids instead of just kids going through a pandemic.

See the rest here:
'I'm definitely disappointed:' incoming freshmen face new set of challenges for the fall | The Retriever - The Retriever

Global Febuxostat Tablets Market: Industry Analysis And Opportunities Assessment, Product Types And Application, Regional Outlook, Leading Players…

Posted on August 31, 2020 by Danzig

Febuxostat Tablets Market

Los Angeles, United State, The report on the global Febuxostat Tablets market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It sheds light on key production, revenue, and consumption trends so that players could improve their sales and growth in the GlobalFebuxostat Tablets Market. It offers a detailed analysis of the competition and leading companies of the global Febuxostat Tablets market. Here, it concentrates on the recent developments, sales, market value, production, gross margin, and other important factors of the business of top players operating in the global Febuxostat Tablets market.

With deep quantitative and qualitative analysis, the report provides encyclopedic and accurate research study on important aspects of the global Febuxostat Tablets market. It brings to light key factors affecting the growth of different segments and regions in the global Febuxostat Tablets market. It also offers SWOT, Porters Five Forces, and PESTLE analysis to thoroughly examine the global Febuxostat Tablets market. It gives a detailed study on manufacturing cost, upstream and downstream buyers, distributors, marketing strategy, and marketing channel development trends of the global Febuxostat Tablets market. Furthermore, it provides strategic bits of advice and recommendations for players to ensure success in the global Febuxostat Tablets market.

Get PDF template of this report:https://www.qyresearch.com/sample-form/form/1701765/covid-19-impact-on-global-febuxostat-tablets-market

Febuxostat Tablets Market Leading Players

, Menarini Group, Takeda Pharmaceuticals, MACLEODS, Prinston Pharmaceutical, Alembic Pharmaceuticals, Hikma Pharmaceuticals, Lupin Limited, Mylan, Teijin Pharma, Hengrui Pharma, Sun Pharma, Msn Laboratories, Golden State Medical, Novadoz Pharmaceuticals, Astellas Pharma, SK Holdings, Ipsen, Hangzhou Zhuyangxin Pharmaceutical, Jiangsu Wanbang Biochemical Pharmaceutical Group, Tianjin Pacific Pharmaceutical Febuxostat Tablets

Product Type:

, 40 Mg Tablet, 80 Mg Tablet, 120 Mg Tablet, 20 Mg Tablet Febuxostat Tablets

By Application:

Hyperuricemia, Tumor Lysis Syndrome, Angina Pectoris, Other

Regions and Countries

The Middle East and Africa(GCC Countries and Egypt)North America(the United States, Mexico, and Canada)South America(Brazil etc.)Europe(Turkey, Germany, Russia UK, Italy, France, etc.)Asia-Pacific(Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Key Questions Answered

What is the size and CAGR of the global Febuxostat Tablets market?

Which are the leading segments of the global Febuxostat Tablets market?

What are the key driving factors of the most profitable regional market?

What is the nature of competition in the global Febuxostat Tablets market?

How will the global Febuxostat Tablets market advance in the coming years?

What are the main strategies adopted in the global Febuxostat Tablets market?

Enquire for customization in Report @https://www.qyresearch.com/customize-request/form/1701765/covid-19-impact-on-global-febuxostat-tablets-market

Table of Contents

1 Study Coverage 1.1 Febuxostat Tablets Product Introduction 1.2 Market Segments 1.3 Key Febuxostat Tablets Manufacturers Covered: Ranking by Revenue 1.4 Market by Type1.4.1 Global Febuxostat Tablets Market Size Growth Rate by Type1.4.2 40 Mg Tablet1.4.3 80 Mg Tablet1.4.4 120 Mg Tablet1.4.5 20 Mg Tablet 1.5 Market by Application1.5.1 Global Febuxostat Tablets Market Size Growth Rate by Application1.5.2 Hyperuricemia1.5.3 Tumor Lysis Syndrome1.5.4 Angina Pectoris1.5.5 Other 1.6 Coronavirus Disease 2019 (Covid-19): Febuxostat Tablets Industry Impact1.6.1 How the Covid-19 is Affecting the Febuxostat Tablets Industry

1.6.1.1 Febuxostat Tablets Business Impact Assessment Covid-19

1.6.1.2 Supply Chain Challenges

1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products1.6.2 Market Trends and Febuxostat Tablets Potential Opportunities in the COVID-19 Landscape1.6.3 Measures / Proposal against Covid-19

1.6.3.1 Government Measures to Combat Covid-19 Impact

1.6.3.2 Proposal for Febuxostat Tablets Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Executive Summary 2.1 Global Febuxostat Tablets Market Size Estimates and Forecasts2.1.1 Global Febuxostat Tablets Revenue 2015-20262.1.2 Global Febuxostat Tablets Sales 2015-2026 2.2 Febuxostat Tablets Market Size by Region: 2020 Versus 20262.2.1 Global Febuxostat Tablets Retrospective Market Scenario in Sales by Region: 2015-20202.2.2 Global Febuxostat Tablets Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Febuxostat Tablets Competitor Landscape by Players 3.1 Febuxostat Tablets Sales by Manufacturers3.1.1 Febuxostat Tablets Sales by Manufacturers (2015-2020)3.1.2 Febuxostat Tablets Sales Market Share by Manufacturers (2015-2020) 3.2 Febuxostat Tablets Revenue by Manufacturers3.2.1 Febuxostat Tablets Revenue by Manufacturers (2015-2020)3.2.2 Febuxostat Tablets Revenue Share by Manufacturers (2015-2020)3.2.3 Global Febuxostat Tablets Market Concentration Ratio (CR5 and HHI) (2015-2020)3.2.4 Global Top 10 and Top 5 Companies by Febuxostat Tablets Revenue in 20193.2.5 Global Febuxostat Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Febuxostat Tablets Price by Manufacturers 3.4 Febuxostat Tablets Manufacturing Base Distribution, Product Types3.4.1 Febuxostat Tablets Manufacturers Manufacturing Base Distribution, Headquarters3.4.2 Manufacturers Febuxostat Tablets Product Type3.4.3 Date of International Manufacturers Enter into Febuxostat Tablets Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Febuxostat Tablets Market Size by Type (2015-2020)4.1.1 Global Febuxostat Tablets Sales by Type (2015-2020)4.1.2 Global Febuxostat Tablets Revenue by Type (2015-2020)4.1.3 Febuxostat Tablets Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Febuxostat Tablets Market Size Forecast by Type (2021-2026)4.2.1 Global Febuxostat Tablets Sales Forecast by Type (2021-2026)4.2.2 Global Febuxostat Tablets Revenue Forecast by Type (2021-2026)4.2.3 Febuxostat Tablets Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Febuxostat Tablets Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026) 5.1 Global Febuxostat Tablets Market Size by Application (2015-2020)5.1.1 Global Febuxostat Tablets Sales by Application (2015-2020)5.1.2 Global Febuxostat Tablets Revenue by Application (2015-2020)5.1.3 Febuxostat Tablets Price by Application (2015-2020) 5.2 Febuxostat Tablets Market Size Forecast by Application (2021-2026)5.2.1 Global Febuxostat Tablets Sales Forecast by Application (2021-2026)5.2.2 Global Febuxostat Tablets Revenue Forecast by Application (2021-2026)5.2.3 Global Febuxostat Tablets Price Forecast by Application (2021-2026) 6 North America 6.1 North America Febuxostat Tablets by Country6.1.1 North America Febuxostat Tablets Sales by Country6.1.2 North America Febuxostat Tablets Revenue by Country6.1.3 U.S.6.1.4 Canada 6.2 North America Febuxostat Tablets Market Facts & Figures by Type 6.3 North America Febuxostat Tablets Market Facts & Figures by Application 7 Europe 7.1 Europe Febuxostat Tablets by Country7.1.1 Europe Febuxostat Tablets Sales by Country7.1.2 Europe Febuxostat Tablets Revenue by Country7.1.3 Germany7.1.4 France7.1.5 U.K.7.1.6 Italy7.1.7 Russia 7.2 Europe Febuxostat Tablets Market Facts & Figures by Type 7.3 Europe Febuxostat Tablets Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Febuxostat Tablets by Region8.1.1 Asia Pacific Febuxostat Tablets Sales by Region8.1.2 Asia Pacific Febuxostat Tablets Revenue by Region8.1.3 China8.1.4 Japan8.1.5 South Korea8.1.6 India8.1.7 Australia8.1.8 Taiwan8.1.9 Indonesia8.1.10 Thailand8.1.11 Malaysia8.1.12 Philippines8.1.13 Vietnam 8.2 Asia Pacific Febuxostat Tablets Market Facts & Figures by Type 8.3 Asia Pacific Febuxostat Tablets Market Facts & Figures by Application 9 Latin America 9.1 Latin America Febuxostat Tablets by Country9.1.1 Latin America Febuxostat Tablets Sales by Country9.1.2 Latin America Febuxostat Tablets Revenue by Country9.1.3 Mexico9.1.4 Brazil9.1.5 Argentina 9.2 Central & South America Febuxostat Tablets Market Facts & Figures by Type 9.3 Central & South America Febuxostat Tablets Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Febuxostat Tablets by Country10.1.1 Middle East and Africa Febuxostat Tablets Sales by Country10.1.2 Middle East and Africa Febuxostat Tablets Revenue by Country10.1.3 Turkey10.1.4 Saudi Arabia10.1.5 UAE 10.2 Middle East and Africa Febuxostat Tablets Market Facts & Figures by Type 10.3 Middle East and Africa Febuxostat Tablets Market Facts & Figures by Application 11 Company Profiles 11.1 Menarini Group11.1.1 Menarini Group Corporation Information11.1.2 Menarini Group Description, Business Overview and Total Revenue11.1.3 Menarini Group Sales, Revenue and Gross Margin (2015-2020)11.1.4 Menarini Group Febuxostat Tablets Products Offered11.1.5 Menarini Group Recent Development 11.2 Takeda Pharmaceuticals11.2.1 Takeda Pharmaceuticals Corporation Information11.2.2 Takeda Pharmaceuticals Description, Business Overview and Total Revenue11.2.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)11.2.4 Takeda Pharmaceuticals Febuxostat Tablets Products Offered11.2.5 Takeda Pharmaceuticals Recent Development 11.3 MACLEODS11.3.1 MACLEODS Corporation Information11.3.2 MACLEODS Description, Business Overview and Total Revenue11.3.3 MACLEODS Sales, Revenue and Gross Margin (2015-2020)11.3.4 MACLEODS Febuxostat Tablets Products Offered11.3.5 MACLEODS Recent Development 11.4 Prinston Pharmaceutical11.4.1 Prinston Pharmaceutical Corporation Information11.4.2 Prinston Pharmaceutical Description, Business Overview and Total Revenue11.4.3 Prinston Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)11.4.4 Prinston Pharmaceutical Febuxostat Tablets Products Offered11.4.5 Prinston Pharmaceutical Recent Development 11.5 Alembic Pharmaceuticals11.5.1 Alembic Pharmaceuticals Corporation Information11.5.2 Alembic Pharmaceuticals Description, Business Overview and Total Revenue11.5.3 Alembic Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)11.5.4 Alembic Pharmaceuticals Febuxostat Tablets Products Offered11.5.5 Alembic Pharmaceuticals Recent Development 11.6 Hikma Pharmaceuticals11.6.1 Hikma Pharmaceuticals Corporation Information11.6.2 Hikma Pharmaceuticals Description, Business Overview and Total Revenue11.6.3 Hikma Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)11.6.4 Hikma Pharmaceuticals Febuxostat Tablets Products Offered11.6.5 Hikma Pharmaceuticals Recent Development 11.7 Lupin Limited11.7.1 Lupin Limited Corporation Information11.7.2 Lupin Limited Description, Business Overview and Total Revenue11.7.3 Lupin Limited Sales, Revenue and Gross Margin (2015-2020)11.7.4 Lupin Limited Febuxostat Tablets Products Offered11.7.5 Lupin Limited Recent Development 11.8 Mylan11.8.1 Mylan Corporation Information11.8.2 Mylan Description, Business Overview and Total Revenue11.8.3 Mylan Sales, Revenue and Gross Margin (2015-2020)11.8.4 Mylan Febuxostat Tablets Products Offered11.8.5 Mylan Recent Development 11.9 Teijin Pharma11.9.1 Teijin Pharma Corporation Information11.9.2 Teijin Pharma Description, Business Overview and Total Revenue11.9.3 Teijin Pharma Sales, Revenue and Gross Margin (2015-2020)11.9.4 Teijin Pharma Febuxostat Tablets Products Offered11.9.5 Teijin Pharma Recent Development 11.10 Hengrui Pharma11.10.1 Hengrui Pharma Corporation Information11.10.2 Hengrui Pharma Description, Business Overview and Total Revenue11.10.3 Hengrui Pharma Sales, Revenue and Gross Margin (2015-2020)11.10.4 Hengrui Pharma Febuxostat Tablets Products Offered11.10.5 Hengrui Pharma Recent Development 11.1 Menarini Group11.1.1 Menarini Group Corporation Information11.1.2 Menarini Group Description, Business Overview and Total Revenue11.1.3 Menarini Group Sales, Revenue and Gross Margin (2015-2020)11.1.4 Menarini Group Febuxostat Tablets Products Offered11.1.5 Menarini Group Recent Development 11.12 Msn Laboratories11.12.1 Msn Laboratories Corporation Information11.12.2 Msn Laboratories Description, Business Overview and Total Revenue11.12.3 Msn Laboratories Sales, Revenue and Gross Margin (2015-2020)11.12.4 Msn Laboratories Products Offered11.12.5 Msn Laboratories Recent Development 11.13 Golden State Medical11.13.1 Golden State Medical Corporation Information11.13.2 Golden State Medical Description, Business Overview and Total Revenue11.13.3 Golden State Medical Sales, Revenue and Gross Margin (2015-2020)11.13.4 Golden State Medical Products Offered11.13.5 Golden State Medical Recent Development 11.14 Novadoz Pharmaceuticals11.14.1 Novadoz Pharmaceuticals Corporation Information11.14.2 Novadoz Pharmaceuticals Description, Business Overview and Total Revenue11.14.3 Novadoz Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)11.14.4 Novadoz Pharmaceuticals Products Offered11.14.5 Novadoz Pharmaceuticals Recent Development 11.15 Astellas Pharma11.15.1 Astellas Pharma Corporation Information11.15.2 Astellas Pharma Description, Business Overview and Total Revenue11.15.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)11.15.4 Astellas Pharma Products Offered11.15.5 Astellas Pharma Recent Development 11.16 SK Holdings11.16.1 SK Holdings Corporation Information11.16.2 SK Holdings Description, Business Overview and Total Revenue11.16.3 SK Holdings Sales, Revenue and Gross Margin (2015-2020)11.16.4 SK Holdings Products Offered11.16.5 SK Holdings Recent Development 11.17 Ipsen11.17.1 Ipsen Corporation Information11.17.2 Ipsen Description, Business Overview and Total Revenue11.17.3 Ipsen Sales, Revenue and Gross Margin (2015-2020)11.17.4 Ipsen Products Offered11.17.5 Ipsen Recent Development 11.18 Hangzhou Zhuyangxin Pharmaceutical11.18.1 Hangzhou Zhuyangxin Pharmaceutical Corporation Information11.18.2 Hangzhou Zhuyangxin Pharmaceutical Description, Business Overview and Total Revenue11.18.3 Hangzhou Zhuyangxin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)11.18.4 Hangzhou Zhuyangxin Pharmaceutical Products Offered11.18.5 Hangzhou Zhuyangxin Pharmaceutical Recent Development 11.19 Jiangsu Wanbang Biochemical Pharmaceutical Group11.19.1 Jiangsu Wanbang Biochemical Pharmaceutical Group Corporation Information11.19.2 Jiangsu Wanbang Biochemical Pharmaceutical Group Description, Business Overview and Total Revenue11.19.3 Jiangsu Wanbang Biochemical Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)11.19.4 Jiangsu Wanbang Biochemical Pharmaceutical Group Products Offered11.19.5 Jiangsu Wanbang Biochemical Pharmaceutical Group Recent Development 11.20 Tianjin Pacific Pharmaceutical11.20.1 Tianjin Pacific Pharmaceutical Corporation Information11.20.2 Tianjin Pacific Pharmaceutical Description, Business Overview and Total Revenue11.20.3 Tianjin Pacific Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)11.20.4 Tianjin Pacific Pharmaceutical Products Offered11.20.5 Tianjin Pacific Pharmaceutical Recent Development 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Febuxostat Tablets Market Estimates and Projections by Region12.1.1 Global Febuxostat Tablets Sales Forecast by Regions 2021-202612.1.2 Global Febuxostat Tablets Revenue Forecast by Regions 2021-2026 12.2 North America Febuxostat Tablets Market Size Forecast (2021-2026)12.2.1 North America: Febuxostat Tablets Sales Forecast (2021-2026)12.2.2 North America: Febuxostat Tablets Revenue Forecast (2021-2026)12.2.3 North America: Febuxostat Tablets Market Size Forecast by Country (2021-2026) 12.3 Europe Febuxostat Tablets Market Size Forecast (2021-2026)12.3.1 Europe: Febuxostat Tablets Sales Forecast (2021-2026)12.3.2 Europe: Febuxostat Tablets Revenue Forecast (2021-2026)12.3.3 Europe: Febuxostat Tablets Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Febuxostat Tablets Market Size Forecast (2021-2026)12.4.1 Asia Pacific: Febuxostat Tablets Sales Forecast (2021-2026)12.4.2 Asia Pacific: Febuxostat Tablets Revenue Forecast (2021-2026)12.4.3 Asia Pacific: Febuxostat Tablets Market Size Forecast by Region (2021-2026) 12.5 Latin America Febuxostat Tablets Market Size Forecast (2021-2026)12.5.1 Latin America: Febuxostat Tablets Sales Forecast (2021-2026)12.5.2 Latin America: Febuxostat Tablets Revenue Forecast (2021-2026)12.5.3 Latin America: Febuxostat Tablets Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Febuxostat Tablets Market Size Forecast (2021-2026)12.6.1 Middle East and Africa: Febuxostat Tablets Sales Forecast (2021-2026)12.6.2 Middle East and Africa: Febuxostat Tablets Revenue Forecast (2021-2026)12.6.3 Middle East and Africa: Febuxostat Tablets Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porters Five Forces Analysis 13.5 Primary Interviews with Key Febuxostat Tablets Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Febuxostat Tablets Customers 14.3 Sales Channels Analysis14.3.1 Sales Channels14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology16.1.1 Methodology/Research Approach16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.

Continue reading here:
Global Febuxostat Tablets Market: Industry Analysis And Opportunities Assessment, Product Types And Application, Regional Outlook, Leading Players...

Global and Asia Pacific Xylenols Market to Witness Huge Growth by 2027 Major Manufacturers included in report Mitsubishi Gas Chemical, Nantong…

Posted on August 31, 2020 by Danzig

Global Coronavirus pandemic has impacted all industries across the globe, Xylenols market being no exception. As Global economy heads towards major recession post 2009 crisis, Cognitive Market Research has published a recent study which meticulously studies impact of this crisis on Global Xylenols market and suggests possible measures to curtail them. This press release is a snapshot of research study and further information can be gathered by accessing complete report. To Contact Research Advisor Mail us @ [emailprotected] or call us on +1-312-376-8303.

Report is a detailed study of the Xylenols market, which covers all the essential information required by a new market entrant as well as the existing players to gain a deeper understanding of the market. Report has been segmented into Geographical Segmentation, Key players, Key Topics Industry Value and Demand Analysis Forecast to 2027 and provides comprehensive investigation.

Global Xylenols Market: Product analysis: Solid, Liquid

Global Xylenols Market: Application analysis: Solvents, Disinfectants, Insecticides, Phenolic Resins Production, Anti Oxidant Manufacturing, Others

Major Market Players with an in-depth analysis: Mitsubishi Gas Chemical, Nantong Xingchen Synthetic Material, Hunan Lijie Biochemical, Rugao Zhongchang Chemical, Changzhou Junchi Chemical, Changzhou City Teng Yang Chemical, Deepak Novochem Technologies

Any query? Enquire Here For Discount (COVID-19 Impact Analysis Updated Sample): Click Here>Download Sample Report of Xylenols Market Report 2020 (Coronavirus Impact Analysis on Xylenols Market)

The research comprises primary information about the products. Similarly, it includes supply-demand statistics, and segments that constrain the growth of an industry. It also includes raw materials used and manufacturing process of Xylenols market. Additionally, report provides market drivers and challenges & opportunities for overall market in the particular provincial sections.

The report gives detailed account on each segment which helps to understand market more effectively. The company profiling of key players include: business overview, product description, research and development investment, key development, business strategy, and SWOT analysis. It also involves sales revenue of each division and geographical coverage for two consecutive years.

Request Free Sample Copy of Xylenols Market Research [emailprotected] https://cognitivemarketresearch.com/chemical-%26-materials/xylenols-market-report#download_report

The industry intelligence study of the Xylenols market covers the estimation size of the market each in phrases of value (Mn/Bn USD) and volume (x units). Further, report consists of Porters Five Forces and BCG matrix as well as product life cycle to help you in taking wise decisions. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Regional Analysis for Xylenols Market:North America (United States, Canada)Europe (Germany, Spain, France, UK, Russia, and Italy)Asia-Pacific (China, Japan, India, Australia, and South Korea)Latin America (Brazil, Mexico, etc.)The Middle East and Africa (GCC and South Africa)

Get A Free Sample of Xylenols Market Report: https://cognitivemarketresearch.com/chemical-%26-materials/xylenols-market-report#download_report

About Us:Cognitive Market Research is one of the finest and most efficient Market Research and Consulting firm. The company strives to provide research studies which include syndicate research, customized research, round the clock assistance service, monthly subscription services, and consulting services to our clients. We focus on making sure that based on our reports, our clients are enabled to make most vital business decisions in easiest and yet effective way. Hence, we are committed to delivering them outcomes from market intelligence studies which are based on relevant and fact-based research across the global market.Contact Us: +1-312-376-8303Email: [emailprotected]Web: https://www.cognitivemarketresearch.com/

Go here to read the rest:
Global and Asia Pacific Xylenols Market to Witness Huge Growth by 2027 Major Manufacturers included in report Mitsubishi Gas Chemical, Nantong...

Ruby Ahaiwe ’21 Focuses Her Public Health Interest on Her Community – Bowdoin News

Posted on August 31, 2020 by Danzig

Before the pandemic, Ahaiwe was also planning a "huge walk for health," as she describes it, in which local people and health care providers walked from the hospital to the local government center to demand more resources for rural health care.

After it became clear that COVID-19 would make it impossible to fly to Nigeria, Ahaiwe established community liaisonsincluding friends and relativeswho could start to educate local people about the importance of taking advantage of local clinics.

"There is a heavy dependency on traditional medicine," Ahaiwe said, "which can work, but people should understand they have a wide range of options for medical care."

Her community partners have been putting up posters Ahaiwe has designed and printed that contain medical advice, such as the importance of handwashing.

The hospital also recently organized a COVID-19 awareness walk to educate community members about the seriousness of the virus. Ahaiwe donated part of her grant to buy face masks and pocket sanitizers to hand out to townspeople.

Working from afar this summer has been successful. But Ahaiwe is a bit worried about how well the community will receive her when she eventually does return to Nigeria. Though her family is from the village, they left the area when she was a child. "Some people might say, 'Who is this young girl telling us how to run our health?'"

To foster community buy-in to her health-outreach projects, Ahaiwe has contacted community leaders, including the local king."Hesaid it was good for the community that young people are coming back to invest in the community and that he would offer whatever support I need,"Ahaiwe said.

Her public health project is the kind of work Ahaiwe wants to dedicate her lifework to. At Bowdoin, she is majoring in biochemistry and minoring in Francophone studies. After college, she plans to earn a master's degree in public health to work in the area of preventative health care, "especially in places with disparities," she said. She would love to be based in Nigeria or somewhere else in Africa, she added.

"This is my focus," she said. "I am passionate about it."

More here:
Ruby Ahaiwe '21 Focuses Her Public Health Interest on Her Community - Bowdoin News

Futurist Transhuman News Blog

Author Archives: Danzig

UM School of Medicines Institute of Human Virology Recruits Top HIV/AIDS Epidemiologist Shenghan Lai Along with Team of Researchers – Newswise

MedMentors On Call aims to provide guidance for premed students – Binghamton University Pipe Dream

Melanie Etti: The A levels fiasco is part of a wider picture of inequality in medical school recruitment – The BMJ – The BMJ

Is The Pandemic Fast-Tracking The Disappearance Of The Physical Exam? : Shots – Health News – NPR

University of Medicine and Health Sciences Launches Dextrocardia Podcast – PR Web

Black Health Matters: New Surgeon at SSM Health Seeks to Raise the Standard of Care for Women of Color – St. Louis American

New med school scholarships to support students from Kentucky – MU The Parthenon

New MCG chief of radiology uses creative imaging to communicate with patients – The Augusta Chronicle

Letter from the Editor: The science of sleep – Medical News Today

Impossible Foods CEO on finding meat’s magical ingredient, pitching VCs and convincing meat-loving chefs to serve a vegan burger – CNBC

Chitosan Market : Global Industry Analysis By Size, Growth Rate, Share, Covid-19 Impact And Trends With Forecast To 2020 2026 | Leading Players-…

Two UGA professors named to National Academy of Inventors – WGAU

Global Clinical Biochemistry Analyzer Market 2020: Competitive Landscape Analysis and Future Outlook by Companies, Key Regions, Types and Application…

Edgar Cahoon: ‘There is still so much basic knowledge to learn’ – Chemistry World

Comprehensive Report on Biochemical Sensors Market by global COVID-19 impact analysis, industry trends, business strategies, opportunities and…

o Aminoanisole Market 2020 Industry Growth by Jiaxing Zhonghua Chemical, WeifangUnion Biochemistry, Seya Industries Ltd, Anhui Haihua Chemical…

‘I’m definitely disappointed:’ incoming freshmen face new set of challenges for the fall | The Retriever – The Retriever

Global Febuxostat Tablets Market: Industry Analysis And Opportunities Assessment, Product Types And Application, Regional Outlook, Leading Players…

Global and Asia Pacific Xylenols Market to Witness Huge Growth by 2027 Major Manufacturers included in report Mitsubishi Gas Chemical, Nantong…

Ruby Ahaiwe ’21 Focuses Her Public Health Interest on Her Community – Bowdoin News